Stockscreener 앱 받기
35.20
3.53%
1.20
시간 외 거래:
35.84
0.64
+1.82%
전일 마감가:
$34.00
열려 있는:
$33.77
하루 거래량:
511.27K
Relative Volume:
0.71
시가총액:
$1.31B
수익:
$272.30M
순이익/손실:
$-5.14M
주가수익비율:
-215.29
EPS:
-0.1635
순현금흐름:
$42.76M
1주 성능:
-0.09%
1개월 성능:
-33.31%
6개월 성능:
-26.48%
1년 성능:
+17.33%
1일 변동 폭
$33.60
$35.59
1주일 범위
$33.02
$35.61
52주 변동 폭
$20.85
$54.85
Harrow Inc Stock (HROW) Company Profile
명칭
Harrow Inc
전화
615.733.4731
주소
1A BURTON HILLS BLVD, NASHVILLE, CA
Compare HROW vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
35.20 | 1.27B | 272.30M | -5.14M | 42.76M | -0.1635 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.42B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.64B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 44.33B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.51B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 22.84B | 3.18B | 1.33B | 1.04B | 27.90 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-12 | 개시 | BTIG Research | Buy |
| 2025-06-10 | 개시 | William Blair | Outperform |
| 2025-02-06 | 개시 | H.C. Wainwright | Buy |
| 2024-12-04 | 재확인 | B. Riley Securities | Buy |
| 2024-04-11 | 개시 | Craig Hallum | Buy |
| 2022-09-08 | 재개 | B. Riley Securities | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2021-09-24 | 개시 | Aegis Capital | Buy |
| 2021-07-02 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Harrow Inc 주식(HROW)의 최신 뉴스
How Investors May Respond To Harrow (HROW) Issuing US$50M In 8.625% Senior Notes For Growth - simplywall.st
Harrow announces $50M add-on senior notes offering - MSN
Fundamentals Check: Is Harrow Inc attractive for institutional investorsNew Guidance & Smart Investment Allocation Tips - baoquankhu1.vn
A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal? - AOL.com
Harrow prices $50M senior unsecured notes due 2030 at 8.625% - MSN
Harrow Health Prices $50 Million Senior Notes Offering - TipRanks
Harrow (NASDAQ: HROW) adds $50M to 8.625% 2030 senior notes - Stock Titan
Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030 - GlobeNewswire
Harrow Announces $50 Million Add-On Offering of 8.625% Senior Unsecured Notes Due 2030 to Support Growth - Minichart
A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal? - The Motley Fool
Harrow to Issue Additional $50 Million Debt Offering - marketscreener.com
Harrow Health Announces $50 Million Senior Notes Offering - TipRanks
Harrow launches $50.0M add-on 8.625% senior notes due 2030 for growth initiatives - TradingView
Harrow (NASDAQ: HROW) plans $50M add-on 8.625% 2030 note issue - Stock Titan
Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth - GlobeNewswire
MongoDB, Surgery Partners, Harrow and other big stocks moving lower in Tuesday's pre-market session - MSN
EnerQuest Technologies Solutions Inc.’s Harrow facility undergoes $15.8M expansion - constructconnect.com
Harrow Health Inc stock faces valuation scrutiny amid eye care expansion push - AD HOC NEWS
HROW Stock Price, Quote & Chart | HARROW INC (NASDAQ:HROW) - ChartMill
HROW: Analyst HC Wainwright & Co. Reiterates 'Buy' with $70 Targ - GuruFocus
Harrow's (HROW) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Harrow (HROW) to Release Quarterly Earnings on Thursday - MarketBeat
Nomura Downgrades Harrow Health, Inc. (HROW) to Neutral March 18, 2026 - Meyka
Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual Meeting - Bitget
Harrow outlines $350M–$365M 2026 revenue goal as sales force expansion and pipeline advances fuel momentum - MSN
HROW: BTIG Reiterates Buy Rating with $63 Price Target | HROW St - GuruFocus
Harrow (NASDAQ:HROW) Given Buy Rating at BTIG Research - MarketBeat
Penn Capital Management Company LLC Makes New Investment in Harrow, Inc. $HROW - MarketBeat
EnerQuest expansion in Essex County to bring jobs, shift production from U.S. - CBC
Harrow Emerging As Dominant Operator In U.S. Ophthalmic Market (NASDAQ:HROW) - Seeking Alpha
Cantor Fitzgerald Initiates Coverage of Harrow (HROW) with Overweight Recommendation - MSN
EnerQuest in Harrow gets support for re-shoring manufacturing - Sarnia News Today
307,337 Shares in Harrow, Inc. $HROW Bought by Luxor Capital Group LP - MarketBeat
Harrow: why this fast-growing eye-care pharma stock is worth a look - Finimize
Braidwell LP Decreases Stock Position in Harrow, Inc. $HROW - MarketBeat
Assessing Harrow (HROW) Valuation After Strong Revenue Growth And TRIESENCE Phase 3 Progress - Sahm
Harrow, Inc. (NASDAQ:HROW) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Why Harrow (HROW) Is Down 6.5% After Raising 2026 Guidance And Advancing TRIESENCE To Phase 3 - simplywall.st
Daniel Kaufman holds 1.878M Harrow shares (HROW) — 5.04% reported - Stock Titan
Harrow Health Projects Robust Growth After Strong 2025 - The Globe and Mail
Harrow Health at Leerink Global Healthcare Conference: Strategic Growth Focus - Investing.com
Harrow (HROW) Q4 2025 Earnings Call Transcript - AOL.com
HROW: Record growth and expanding ophthalmic portfolio drive optimism for future launches - TradingView
Harrow (NASDAQ: HROW) furnishes March 2026 corporate investor presentation - Stock Titan
Harrow Inc (HROW) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions - Investing.com Canada
Harrow Inc (HROW) Q4 2025 Earnings Call Highlights: Record Reven - GuruFocus
HARROW INCHROW 8 5/8 04/30/26 (HROWL) Earnings History & Surprises - ChartMill
Is Harrow Inc. stock a top pick in earnings seasonTrade Performance Summary & Safe Entry Point Alerts - Naître et grandir
Harrow, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:HROW) 2026-03-06 - Seeking Alpha
Has The Recent Slide In Harrow (HROW) Opened A Valuation Opportunity For Investors - simplywall.st
HC Wainwright Issues Negative Forecast for Harrow Earnings - MarketBeat
Harrow Inc (HROW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.75%
1.88%
자본화:
|
볼륨(24시간):